Status
Conditions
Treatments
About
This trial aims to evaluate the impact on cardiovascular risk control in individuals in risk of being affected by hepatic steatosis through the implementation of a screening test (Fatty Liver Index) in Primary Care. Medical teams in a primary care center will be divided into 2 groups, with one group using the screening test in their clinical practice. The number of interventions on cardiovascular risk occurring in patients attended by each group of medical teams will be evaluated and compared.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
434 participants in 2 patient groups
Loading...
Central trial contact
M Carmen Rosas, MD; Noemí Casaponsa
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal